Tag : Granules Pharmaceuticals FDA approval

Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)

NewsmantraDecember 22, 2025

by NewsmantraDecember 22, 20250

Bengaluru, December 22, 2025 – Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More